Form D · Biotechnology
Liquidia Corp
Morrisville, NC · CIK 0001819576
Offering snapshot reported Apr 16, 2021 · SEC filing
- Reported sold
- $21.7M Offering amount: $21.7M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 13, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 16, 2021 | Initial | $21,737,613 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-396169
Source: Form D, filed Apr 16, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Bloch | Director |
| Damian De Goa | Director, Executive |
| Joanna Horobin | Director |
| Roger A. Jeffs | Director |
| David Johnson | Director |
| Michael Kaseta | Executive |
| Arthur Kirsch | Director |
| Paul B. Manning | Director |
| Katherine Rielly Gauvin | Director |
| Raman Singh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
419 Davis Drive Suite 100
Morrisville, NC, 27560
Morrisville, NC, 27560